CAZZANIGA MARINA ELENA

Ruolo:

Ricercatore a tempo determinato

Settore scientifico disciplinare:

ONCOLOGIA MEDICA (MED/06)

Afferenza:

E-mail:

Krasniqi, E., Pizzuti, L., Barchiesi, G., Sergi, D., Carpano, S., Botti, C., et al. (2020). Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence. JOURNAL OF CELLULAR PHYSIOLOGY. Dettaglio
Jacobs, S., Robidoux, A., Abraham, J., Pérez-Garcia, J., La Verde, N., Orcutt, J., et al. (2020). Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer. BREAST CANCER RESEARCH, 22(1). Dettaglio
Pizzuti, L., Krasniqi, E., Barchiesi, G., Della Giulia, M., Izzo, F., Sanguineti, G., et al. (2020). Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting. INTERNATIONAL JOURNAL OF CANCER, 146(7), 1917-1929. Dettaglio
Ellinghaus, D., Degenhardt, F., Bujanda, L., Buti, M., Albillos, A., Invernizzi, P., et al. (2020). Genomewide Association Study of Severe Covid-19 with Respiratory Failure. NEW ENGLAND JOURNAL OF MEDICINE. Dettaglio
Cavaletti, G., Cornblath, D., Merkies, I., Postma, T., Rossi, E., Alberti, P., et al. (2019). Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 24(1), 111-119. Dettaglio

Futuri studenti